Evidence map›Paper›PMID 31919944›Full record

ArticleHead & neck2020

Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer.

Benjamin R Roman, Shivangi Lohia, Nandita Mitra, Marilene B Wang, Anna M Pou, F Christopher Holsinger, David Myssiorek, David Goldenberg, David A Asch, Judy A Shea

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Head & neck, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Benjamin R RomanHead and Neck Service, Memorial Sloan Kettering Cancer Center, New York.
Shivangi LohiaHead and Neck Service, Memorial Sloan Kettering Cancer Center, New York.ORCID 0000-0003-2335-3581
Nandita MitraPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Marilene B WangDepartment of Head and Neck Surgery, University of California, Los Angeles, California.
Anna M PouDepartment of Otolaryngology, Ochsner Health System, Covington, Louisiana.
F Christopher HolsingerDepartment of Otolaryngology, Stanford University, Stanford, California.
David MyssiorekDepartment of Surgery, Division of Otolaryngology Head and Neck Surgery, The Albert College of Medicine, Bronx, New York.ORCID 0000-0003-3646-5259
David GoldenbergDivision of Otolaryngology-Head and Neck Surgery, Department of Surgery, The Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, Pennsylvania.
David A AschPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Judy A SheaPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
University of Pennsylvania · USMemorial Sloan Kettering Cancer Center · USAlbert Einstein College of Medicine · USOchsner Health System · USPennsylvania State University · USStanford Medicine · USUniversity of California, Los Angeles · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundWhy physicians use surveillance imaging for asymptomatic cancer survivors despite recommendations against this is not known.

methodsPhysicians surveilling head and neck cancer survivors were surveyed to determine relationships among attitudes, beliefs, guideline familiarity, and self-reported surveillance positron-emission-tomography/computed-tomography use.

resultsAmong 459 responses, 79% reported using PET/CT on some asymptomatic patients; 39% reported using PET/CT on more than half of patients. Among attitudes/beliefs, perceived value of surveillance imaging (O.R. 3.57, C.I. 2.42-5.27, P = <.0001) was the strongest predictor of high imaging, including beliefs about outcome (improved survival) and psychological benefits (reassurance, better communication). Twenty-four percent of physicians were unfamiliar with guideline recommendations against routine surveillance imaging. Among physicians with high perceived-value scores, those less familiar with guidelines imaged more (O.R. 3.55, C.I. 1.08-11.67, P = .037).

conclusionsInterventions to decrease routine surveillance PET/CT use for asymptomatic patients must overcome physicians' misperceptions of its value. Education about guidelines may modify the effect of perceived value.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsPhysiciansFluorodeoxyglucose F18HumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyTomography, X-Ray ComputedFluorodeoxyglucose F18head and neck cancerPET/CTphysician decision-makingsurveillance imagingvalue

Identifiers

PMID31919944
PMCPMC7654549
OpenAlexW2999756491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.